Saltar al contenido
Sueño y ritmosEnsayo aleatorizado4 min read

Acupuncture did not beat sham on insomnia score after breast cancer chemo

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Acupuncture for chemotherapy-associated insomnia in breast cancer patients: an assessor-participant blinded, randomized, sham-controlled trial. · Breast cancer research : BCR · 2023 · Artículo original ↗

Idea principal

In 138 breast cancer patients with chemotherapy-associated insomnia, real acupuncture was not better than sham acupuncture at lowering Insomnia Severity Index score at 6 weeks (mean difference -0.4, 95% CI -1.8 to 1.1; P = 0.609). Several secondary outcomes favored acupuncture, but they are secondary results from a single-region trial, so they need confirmation.

Study design

Ensayo aleatorizado

Reading basis

Published abstract

Reading focus

Comparator & uncertainty

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Insomnia is very common during and after chemotherapy, and acupuncture may help. The authors tested whether a combined regimen of body needling and ear acupressure improves chemotherapy-associated insomnia in breast cancer patients, and whether it is safe.

Población y método

Assessor- and participant-blinded, randomized, sham-controlled trial run from November 2019 to January 2022 (follow-up completed July 2022). Oncologists at two Hong Kong hospitals referred participants, and treatment took place at an outpatient clinic of the University of Hong Kong. A total of 138 patients were randomized equally (69 each) to 15 sessions of active acupuncture (body acupoint needling plus auricular acupressure) or sham acupuncture over 18 weeks, followed by 24 weeks of follow-up. The primary outcome was the Insomnia Severity Index (ISI). Secondary outcomes included the Pittsburgh Sleep Quality Index, Actiwatch and sleep diary sleep parameters, depression, anxiety, fatigue, pain and quality of life.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    The primary endpoint at week 6 was completed by 87.7% (121/138) of participants. Active acupuncture was not superior to sham in reducing ISI score from baseline to 6 weeks (mean difference -0.4, 95% CI -1.8 to 1.1; P = 0.609).
  2. 2
    The authors report better short-term and long-term follow-up outcomes with active acupuncture for sleep onset latency, total sleep time, sleep efficiency, anxiety, depression and quality of life. The abstract gives no numbers for these.
  3. 3
    Cessation of sleeping medications was higher in the active acupuncture group than in the sham group (56.5% vs. 14.3%, P = 0.011); the abstract does not give the number of people using medication.
  4. 4
    All treatment-related adverse events were mild, and no participants stopped treatment because of them.

Límites e incertidumbre

  1. 1
    The primary outcome was null, so the conclusion that acupuncture is effective rests on secondary outcomes without correction for multiple comparisons mentioned in the abstract.
  2. 2
    Medication cessation percentages come from what appears to be a small subgroup of medication users, and the abstract does not report their numbers.
  3. 3
    Participants were from two Hong Kong hospitals and treated at one university clinic, and 121 of 138 completed the primary endpoint.
  4. 4
    This reading is based on the abstract only.

Relevancia práctica

Acupuncture did not lower the main insomnia score more than sham needling, so this trial does not prove it works for chemotherapy insomnia, though some sleep, mood and quality-of-life measures looked better. Anyone using sleeping medication should not change it based on this study; discuss options with your oncology team.

Tus datos

Sleep diaries and wrist-worn trackers can show total sleep time and sleep efficiency, two measures this trial followed with an Actiwatch and diary. Wearable sleep estimates are not as accurate as research devices, so compare your own weekly averages from the same device rather than single nights.

Cómo interpretar la evidencia

Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

Insomnia is a highly prevalent symptom occurred during and post-chemotherapy. Acupuncture may have beneficial effects in the management of chemotherapy-associated insomnia. This study was conducted to determine the efficacy and safety of acupuncture in improving chemotherapy-associated insomnia in breast cancer patients.

Methods

This assessor-participant blinded, randomized, sham-controlled trial was conducted from November 2019 to January 2022 (follow-up completed July 2022). Participants were referred by oncologists from two Hong Kong hospitals. Assessments and interventions were conducted at the outpatient clinic of School of Chinese Medicine, the University of Hong Kong. The 138 breast cancer patients with chemotherapy-associated insomnia were randomly assigned to receive either 15 sessions of active acupuncture regimen by combining needling into body acupoints and acupressure on auricular acupoints or sham acupuncture control (69 each) for 18 weeks, followed by 24 weeks of follow-up. The primary outcome was measured using Insomnia Severity Index (ISI). Secondary outcomes included the Pittsburgh Sleep Quality Index, Actiwatch and sleep diary for sleep parameters, depression and anxiety, fatigue and pain, and quality of life.

Results

There were 87.7% (121/138) participants who completed the primary endpoint (week-6). The active acupuncture regimen was not superior to the sham control in reducing ISI score from baseline to 6 weeks (mean difference: - 0.4, 95% CI - 1.8-1.1; P = 0.609), but produced short-term treatment and long-term follow-up better outcomes in improving sleep onset latency, total sleep time, sleep efficiency, anxiety, depression, and quality of life. Participants of the active acupuncture group had a pronouncedly higher cessation rate of sleeping medications than the sham control (56.5% vs. 14.3%, P = 0.011). All treatment-related adverse events were mild. No participants discontinued treatments due to adverse events.

Conclusion

The active acupuncture regimen could be considered as an effective option for the management of chemotherapy-associated insomnia. It also could serve as a tapering approach to reduce and even replace the use of sleeping medications in breast cancer patients. Trial registration Clinicaltrials.gov : NCT04144309. Registered 30 October 2019.

Fuentes y atribución

Acupuncture for chemotherapy-associated insomnia in breast cancer patients: an assessor-participant blinded, randomized, sham-controlled trial.

Zhang J, Qin Z, So TH, Chang TY, Yang S, Chen H, Yeung WF, Chung KF, Chan PY, Huang Y, Xu S, Chiang CY, Lao L, Zhang ZJ.

Breast cancer research : BCR · 2023-04-26

DOI: 10.1186/s13058-023-01645-0 ↗PubMed · 37101228 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Metaanálisis de ensayos

Exercise improved sleep-quality scores in adults 45 and older with sleep disorders

Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.

Journal of Exercise Science & Fitness

Explicaciones detalladasLeer estudio →
·Estudio de cohorte

Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults

Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.

Sleep

Explicaciones detalladasLeer estudio →
·Ensayo aleatorizado

Sleep extension cut daily energy intake by about 270 kcal in adults with overweight

In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.

JAMA Internal Medicine

Explicaciones detalladasLeer estudio →
·Estudio de cohorte

Six hours or less of sleep at 50 and 60 linked to higher dementia risk

In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.

Nature Communications

Explicaciones detalladasLeer estudio →
Sueño y ritmos →